2005
DOI: 10.1016/j.bmc.2005.04.078
|View full text |Cite
|
Sign up to set email alerts
|

Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 44 publications
(18 citation statements)
references
References 13 publications
0
18
0
Order By: Relevance
“… a TPA concentration is 32 pmol/mL b logCureP represents a log10 transformed response fingerprint values, as described in reference 45 c Values in parentheses represent viability percentages of Raji cells. For the determination of cytotoxicity, the cell viability is required greater than 60 %…”
Section: Figmentioning
confidence: 99%
“… a TPA concentration is 32 pmol/mL b logCureP represents a log10 transformed response fingerprint values, as described in reference 45 c Values in parentheses represent viability percentages of Raji cells. For the determination of cytotoxicity, the cell viability is required greater than 60 %…”
Section: Figmentioning
confidence: 99%
“…27 In other work on phenyl quinolines, 2-(4-phenylquinolin-2-yl)phenol derivatives produced significant anti-inflammatory, analgesic and antipyretic activities and demonstrated efficient inhibition of the COX-2 enzyme. 28 A number of substituted 2-phenylquinolines displayed superior ERβ affinity in a cellbased transcriptional assay, 29 potent antiplatelet activities, 30 antimitotic activity, [31][32][33] and antiproliferative activity against the growth of certain cancer cells such as HCT-116 (colon cancer), MCF7 (breast cancer), and MDA-MB-435 (breast cancer) with low GI 50 values. 34 Previously, we carried out the bromination of 1,2,3,4-tetrahydroquinoline (1) 15,35,36 with molecular bromine leading to the formation of polyfunctional quinoline derivatives, which was followed by transformation into their respective derivatives.…”
Section: Introductionmentioning
confidence: 99%
“…The development of antibiotic quinolone begun in 1962 with the discovery of nalidixic acid which was used to treat urinary tract infections (Lesher et al, 1962). Many diversely substituted 4-quinolones have been extensively investigated as anti-tumour (Nakamura et al, 2005), anti-viral (Santos et al, 2009), anti-diabetic (Edmont et al, 2000), anti-trypanosomal (Wube et al, 2011) and anti-malarial agents (Vinayaka et al, 2014). As part of our studies in this area, the title compound was synthesized to study its crystal structure.…”
Section: Structure Descriptionmentioning
confidence: 99%